Literature DB >> 22336524

[Post-menopausal ovarian hyperthecosis].

A-L Castell1, S Hieronimus, A Chevallier, J-L Sadoul, M-B Galand-Portier, J Delotte, P Fénichel.   

Abstract

Ovarian hyperthecosis is infrequent but it represents the first cause of post-menopausal hyperandrogenia. Pathophysiology of ovarian hyperthecosis remains poorly understood but the metabolic syndrome observed in most patients suggests that insulin resistance associated with high, postmenopausal LH levels, might play a role as in polycystic ovarian syndrome. We report here four patients who presented post-menopausal hyperandrogenia. Although high, tumoral, plasma testosterone levels, lack of focused radiological lesions except enlarged ovaries, associated to the metabolic syndrome, suggested ovarian hyperthecosis. Bilateral annexectomy allowed histological confirmation of hyperthecosis showing specific luteinized stromal cells and led to the complete suppression of the inappropriate androgen secretion.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336524     DOI: 10.1016/j.gyobfe.2011.07.049

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  2 in total

1.  Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization.

Authors:  Thaís Rocha; Raiane P Crespo; Viviane V R Yance; Sylvia A Hayashida; Edmund C Baracat; Filomena Carvalho; Sorahia Domenice; Berenice B Mendonca; Larissa G Gomes
Journal:  J Endocr Soc       Date:  2019-04-04

2.  Virilization and metabolic disease in postmenopausal women related to ovarian hyperplasia and hypertecosis

Authors:  Agustina Lucila Larrea; Vicente Ricardo González; Pablo Knoblovits; Santiago José Gil
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.